Aperam Q1 2026 slides: best quarter in three years, €700-800m EBITDA path

Aperam reported Q1 2026 adjusted EBITDA of €90 million, up 34% quarter-on-quarter, with sales rising 16% to €1.575 billion and operating income swinging to €34 million from a €29 million loss. The company guided to higher Q2 EBITDA, kept 2026 capex at about €200 million, and reiterated its €2.00 per-share base dividend, while also advancing its €700-800 million normalized EBITDA target by 2028. Offseting the beat, free cash flow was negative €44 million and net financial debt rose to €1.057 billion amid seasonal working capital build.

Analysis

The setup is better than the headline suggests: this is a classic late-cycle industrial earnings inflection where operating leverage is improving before end-market demand does. The key second-order effect is inventory and working-capital normalization — if management is right that Q2 releases cash while margins expand, the market may start pricing a faster deleveraging path, which matters more than near-term EPS in a capital-intensive name. That can also re-rate European cyclicals more broadly if peers are still anchored to weak utilization assumptions.

The most investable angle is not stainless steel demand itself, but Aperam’s exposure to policy-supported substitution. Reduced import pressure plus CBAM creates a quasi-protected margin corridor in Europe, while the Brazil bottleneck spend is a low-risk capacity add that should improve mix into higher-value domestic demand. Magnetec is strategically more important than it looks: it nudges the business toward EV/electrification content, which can partially decouple earnings from traditional stainless cycles and justify a higher terminal multiple if execution holds.

The main risk is that the market extrapolates one seasonal quarter into a structural recovery. If energy prices remain volatile or raw-material pass-through lags, the operating leverage cuts both ways and leverage can stay stuck near the current zone longer than bulls expect. A subtler risk is that CBAM/import relief gets competed away through lagged trade flows, limiting the margin rebound to utilization rather than price — that would cap upside to a tactical trade rather than a multi-quarter rerating.

Contrarian view: the stock may be under-owned for the wrong reason. Investors likely dismiss it as a low-growth commodity processor, but the combination of a disciplined capital return policy, visible structural cost takeout, and optionality from downstream magnetic components creates a cleaner “self-help plus policy tailwind” story than the sector typically offers. The move is not overdone if Q2 confirms cash conversion; if not, it becomes a dead-cat seasonal bounce.

Key Decisions for Investors

• Long APAM on weakness into the next 2-4 weeks; target a 10-15% rerating if Q2 confirms lower debt and positive cash conversion, with downside limited by dividend support and already-improved utilization.
• Pair trade: long APAM / short a more commodity-beta European industrial metals name over 1-3 months; thesis is that Aperam has idiosyncratic policy and self-help support while the peer lacks the same cash-flow visibility.
• Buy APAM 3-6 month call spreads to express a Q2 deleveraging catalyst with defined downside; structure for a modest move higher rather than a full cycle revaluation.
• Avoid chasing the rally if raw-material volatility spikes; use any post-earnings strength to trim into resistance near the prior high because the market may be front-running seasonal improvement already.
• If you want cleaner policy exposure, consider a basket long in European low-carbon industrials versus energy-intensive cyclicals; Aperam is the clearest single-name proxy from this setup.